Dezhan Healthcare Company Limited

000813

CNE000000VV8

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
2.54 ^CNY	+2.42%		-0.78%	-22.32%

24/04	Dezhan Healthcare Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
11/04	Dezhan Healthcare Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Tranche Update on Dezhan Healthcare Company Limited's Equity Buyback Plan announced on September 7, 2022.

October 12, 2022 at 01:01 am IST

From September 6, 2022 to September 30, 2022, the company has repurchased 8,216,401 shares, representing 0.37% for CNY 25.81 million. With this, the company has completed the repurchase of 8,216,401 shares, representing 0.37% for CNY 25.81 million under the buyback announced on September 7, 2022.

Latest news about Dezhan Healthcare Company Limited

Dezhan Healthcare Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	24/04	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Full Year Ended December 31, 2023	11/04	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2023	25/23/25	CI
Dezhan Healthcare Company Limited completed the acquisition of additional 18% stake in Shanghai Deyi Pharmaceutical Co., Ltd. from Hanyi Biotechnology Co., Ltd.	16/23/16	CI
Dezhan Healthcare to Boost Stake in Deyi Pharmaceutical for 37.8 Million Yuan; Shares Slump 8%	28/23/28	MT
Dezhan Healthcare Company Limited agreed to acquire additional 18% stake in Shanghai Deyi Pharmaceutical Co., Ltd. from Hanyi Biotechnology Co., Ltd. for CMY 37.8 million.	27/23/27	CI
Dezhan Healthcare Company Limited(XSEC:000813) added to S&P Global BMI Index	18/23/18	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23/23/23	CI
Dezhan HealthCare Chairman Resigns	29/23/29	MT
Tranche Update on Dezhan Healthcare Company Limited's Equity Buyback Plan announced on September 7, 2022.	26/23/26	CI
Equity Buyback announced on September 7, 2022 has expired with 52,913,582 shares, representing 2.33% for CNY 180.26 million.	25/23/25	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2023	27/23/27	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Full Year Ended December 31, 2022	27/23/27	CI
Tranche Update on Dezhan Healthcare Company Limited's Equity Buyback Plan announced on September 7, 2022.	05/23/05	CI
Dezhan HealthCare Earmarks 489 Million Yuan on Medical Health Complex Project	01/23/01	MT
Tranche Update on Dezhan Healthcare Company Limited's Equity Buyback Plan announced on September 7, 2022.	03/23/03	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2022	27/22/27	CI
Tranche Update on Dezhan Healthcare Company Limited's Equity Buyback Plan announced on September 7, 2022.	12/22/12	CI
Dezhan HealthCare Settles Litigation With Former Investment Partner	04/22/04	MT
Dezhan Healthcare Company Limited commences an Equity Buyback Plan for CNY 345 million, under the authorization approved on May 26, 2022.	07/22/07	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Half Year Ended June 30, 2022	24/22/24	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the First Quarter Ended March 31, 2022	29/22/29	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Full Year Ended December 31, 2021	26/22/26	CI
Dezhan Healthcare Company Limited Reports Earnings Results for the Nine Months Ended September 30, 2021	25/21/25	CI
Dezhan Healthcare Company Limited Announces Executive Appointments	02/21/02	CI

Chart Dezhan Healthcare Company Limited

Duration

Period

More charts

Company Profile

Dezhan HealthCare Co Ltd, formerly Xinjiang Tianshan Wool Tex Stock Co Ltd, is a China-based company mainly engaged in the research and development, production and sales of pharmaceuticals. The Company focuses on cardiovascular and cerebrovascular drugs, anti-cancer drugs, health care products, functional beverages, ecological water and other fields. Its subsidiaries optimize the structure of combined products, introduce production lines that meet the production needs of multiple dosage forms according to product development needs, and increase products such as injections, biopharmaceuticals, and Chinese medicine preparations. The Company mainly conducts its businesses in the China market.

Sector

Pharmaceuticals

Calendar

22/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
DEZHAN HEALTHCARE COMPANY LIMITED	-22.32%	76Cr
ELI LILLY AND COMPANY	+40.73%	74TCr
NOVO NORDISK A/S	+32.83%	60TCr
JOHNSON & JOHNSON	-6.30%	35TCr
MERCK & CO., INC.	+15.15%	32TCr
ABBVIE INC.	+4.05%	28TCr
ASTRAZENECA PLC	+15.00%	24TCr
ROCHE HOLDING AG	-5.52%	21TCr
AMGEN INC.	+6.17%	16TCr
PFIZER, INC.	-0.45%	16TCr

Other Pharmaceuticals

Dezhan Healthcare Company Limited

Equities

000813

CNE000000VV8

Pharmaceuticals

Tranche Update on Dezhan Healthcare Company Limited's Equity Buyback Plan announced on September 7, 2022.

Latest news about Dezhan Healthcare Company Limited

Chart Dezhan Healthcare Company Limited

Company Profile

Income Statement Evolution

Annual profits - Rate of surprise

Sector Other Pharmaceuticals